Postpolycythaemic myelofibrosis: Frequency and risk factors for this complication in 116 patients

British Journal of Haematology

Volumn 146, Issue 5, 2009, Pages 504-509

  Alvarez Larrán, Alberto ^a   Bellosillo, Beatriz ^a   Martínez Avilés, Luz ^a   Saumell, Silvia ^a   Salar, Antonio ^a   Abella, Eugenia ^a   Gimeno, Eva ^a   Serrano, Sergi ^a   Florensa, Lourdes ^a   Sánchez, Blanca ^a   Pedro, Carmen ^a   Besses, Carles ^a  

^a INST MUNIC D INVESTIGACIO MEDICA   (Spain)

Author keywords

JAK2; Myelofibrosis; Polycythaemia vera

Indexed keywords

ACENOCOUMAROL; ACETYLSALICYLIC ACID; ALPHA INTERFERON; ANAGRELIDE; BUSULFAN; DANAZOL; HYDROXYUREA; JANUS KINASE 2; LACTATE DEHYDROGENASE; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; PHOSPHORUS; THALIDOMIDE;

ADULT; AGED; ARTICLE; CYTOREDUCTIVE SURGERY; DISEASE PREDISPOSITION; FEMALE; FOLLOW UP; GENE MUTATION; HETEROZYGOSITY; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MYELOFIBROSIS; PHLEBOTOMY; POLYCYTHEMIA VERA; POSTPOLYCYTHEMIC MYELOFIBROSIS; PRIORITY JOURNAL; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; HETEROZYGOTE; HUMANS; INCIDENCE; JANUS KINASE 2; KAPLAN-MEIERS ESTIMATE; L-LACTATE DEHYDROGENASE; MALE; MEGAKARYOCYTES; MIDDLE AGED; MUTATION; POLYCYTHEMIA VERA; PRIMARY MYELOFIBROSIS; PROBABILITY; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 68949211425     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2009.07804.x     Document Type: Article

References (29)

1. Barosi G., Mesa, R.A., Thiele, J., Cervantes, F., Campbell, P.J., Verstovsek, S., Dupriez, B., Levine, R.L., Passamonti, F., Gotlib, J., Reilly, J.T., Vannucchi, A.M., Hanson, C.A., Solberg, L.A., Orazi, A. Tefferi, A. (2008) Proposed criteria for the diagnosis of postpolycythemia vera and postessential thrombocythemia myelofibrosis: a consensus statement from the international working group for myelofibrosis research and treatment. Leukemia, 22, 437 438.
2. Castro-Malaspina, H., Rabellino, E.M., Yen, A., Nachman, R.L. Moore, M.A. (1981) Human megakaryocyte stimulation of proliferation of bone marrow fibroblasts. Blood, 57, 781 787.
3. Cervantes, F., Alvarez-Larrán, A., Talarn, C., Gomez, M. Montserrat, E. (2002) Myelofibrosis with myeloid metaplasia following essential thrombocythaemia: actuarial probability, presenting characteristics and evolution in a series of 195 patients. British Journal of Haematology, 118, 786 790.
4. Chievitz, E. Thiede, T. (1962) Complications and causes of death in polycythaemia vera. Acta Medica Scandinavica, 172, 513 523.
5. Ciurea, S.O., Merchant, D., Mahmud, N., Ishii, T., Zhao, Y., Hu, W., Bruno, E., Barosi, G., Xu, M. Hoffman, R. (2007) Pivotal contributions of megakaryocytes to the biology of idiopathic myelofibrosis. Blood, 110, 986 993.
6. Ellis, J.T., Peterson, P., Geller, S.A. Rappaport, H. (1986) Studies of the bone marrow in polycythemia vera and the evolution of myelofibrosis and second hematologic malignancies. Seminars in Hematology, 23, 144 155.
7. Florensa, L., Besses, C., Woessner, S., Sole, F., Acin, P., Pedro, C. Sans-Sabrafen, J. (1995) Endogenous megakaryocyte and erythroid colony formation from blood in essential thrombocythaemia. Leukemia, 9, 271 273.
8. Gruppo Italiano Studio Policitemia (1995) Polycythemia vera: the natural history of 1213 patients followed for 20 years. Gruppo Italiano Studio Policitemia. Annals of Internal Medicine, 123, 656 664.
9. James, C., Ugo, V., Le Couedic, J.P., Staerk, J., Delhommeau, F., Lacout, C., Garcon, L., Raslova, H., Berger, R., naceur-Griscelli, A., Villeval, J.L., Constantinescu, S.N., Casadevall, N. Vainchenker, W. (2005) A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature, 434, 1144 1148.
10. Katoh, O., Kimura, A. Kuramoto, A. (1988) Platelet-derived growth factor is decreased in patients with myeloproliferative disorders. American Journal of Hematology, 27, 276 280.
11. Kimura, A., Katoh, O. Kuramoto, A. (1988) Effects of platelet derived growth factor, epidermal growth factor and transforming growth factor-beta on the growth of human marrow fibroblasts. British Journal of Haematology, 69, 9 12.
12. Kimura, A., Katoh, O., Hyodo, H. Kuramoto, A. (1989) Transforming growth factor-beta regulates growth as well as collagen and fibronectin synthesis of human marrow fibroblasts. British Journal of Haematology, 72, 486 491.
13. Le Bousse-Kerdiles, M.C. Martyre, M.C. (1999) Dual implication of fibrogenic cytokines in the pathogenesis of fibrosis and myeloproliferation in myeloid metaplasia with myelofibrosis. Annals of Hematology, 78, 437 444.
14. Levine, R.L., Belisle, C., Wadleigh, M., Zahrieh, D., Lee, S., Chagnon, P., Gilliland, D.G. Busque, L. (2006) X-inactivation-based clonality analysis and quantitative JAK2V617F assessment reveal a strong association between clonality and JAK2V617F in PV but not ET/MMM, and identifies a subset of JAK2V617F-negative ET and MMM patients with clonal hematopoiesis. Blood, 107, 4139 4141.
15. Marchioli, R., Finazzi, G., Landolfi, R., Kutti, J., Gisslinger, H., Patrono, C., Marilus, R., Villegas, A., Tognoni, G. Barbui, T. (2005) Vascular and neoplastic risk in a large cohort of patients with polycythemia vera. Journal of Clinical Oncology: Official Journal of The American Society of Clinical Oncology, 23, 2224 2232.
16. Moliterno, A.R., Williams, D.M., Rogers, O., Isaacs, M.A. Spivak, J.L. (2008) Phenotypic variability within the JAK2 V617F-positive MPD: roles of progenitor cell and neutrophil allele burdens. Experimental Hematology, 36, 1480 1486.
17. Najean, Y., Dresch, C. Rain, J.D. (1994) The very-long-term course of polycythaemia: a complement to the previously published data of the polycythaemia vera study group. British Journal of Haematology, 86, 233 235.
18. Passamonti, F., Rumi, E., Caramella, M., Elena, C., Arcaini, L., Boveri, E., Del, C.C., Pietra, D., Vanelli, L., Bernasconi, P., Pascutto, C., Cazzola, M., Morra, E. Lazzarino, M. (2008) A dynamic prognostic model to predict survival in postpolycythemia vera myelofibrosis. Blood, 111, 3383 3387.
19. Pearson, T.C. (2001) Evaluation of diagnostic criteria in polycythemia vera. Seminars in Hematology, 38, 21 24.
20. Perkins, J., israuels, M.C. Wilkinson, J.F. (1964) Polycythaemia vera: clinical studies on a series of 127 patients managed without radiation therapy. The Quarterly Journal of Medicine, 33, 499 518.
21. Randi, M.L., Barbone, E., Fabris, F., Varotto, L., Macri, C. Girolami, A. (1994) Postpolycythemia myeloid metaplasia: experience with a large cohort of patients. Journal of Medicine, 25, 363 369.
22. Silverstein, M.N. (1974) Postpolycythemia myeloid metaplasia. Archives of Internal Medicine, 134, 113 117.
23. Silverstein, M.N. (1976) The evolution into and the treatment of late stage polycythemia vera. Seminars in Hematology, 13, 79 84.
24. Spivak, J.L. (2002) Polycythemia vera: myths, mechanisms and management. Blood, 100, 4272 4290.
25. Taksin, A.L., Couedic, J.P., Dusanter-Fourt, I., Masse, A., Giraudier, S., Katz, A., Wendling, F., Vainchenker, W., Casadevall, N. Debili, N. (1999) Autonomous megakaryocyte growth in essential thrombocythemia and idiopathic myelofibrosis is not related to a c-mpl mutation or to an autocrine stimulation by Mpl-L. Blood, 93, 125 139.
26. Tefferi, A., Lasho, T.L., Schwager, S.M., Strand, J.S., Elliott, M., Mesa, R., Li, C.Y., Wadleigh, M., Lee, S.J. Gilliland, D.G. (2006) The clinical phenotype of wild-type, heterozygous, and homozygous JAK2V617F in polycythemia vera. Cancer, 106, 631 635.
27. Vannucchi, A.M., Antonioli, E., Guglielmelli, P., Longo, G., Pancrazzi, A., Ponziani, V., Bogani, C., Ferrini, P.R., Rambaldi, A., Guerini, V., Bosi, A. Barbui, T. (2007a) Prospective identification of high-risk polycythemia vera patients based on JAK2(V617F) allele burden. Leukemia, 21, 1952 1959.
28. Vannucchi, A.M., Antonioli, E., Guglielmelli, P., Rambaldi, A., Barosi, G., Marchioli, R., Marfisi, R.M., Finazzi, G., Guerini, V., Fabris, F., Randi, M.L., De, S.V., Caberlon, S., Tafuri, A., Ruggeri, M., Specchia, G., Liso, V., Rossi, E., Pogliani, E., Gugliotta, L., Bosi, A. Barbui, T. (2007b) Clinical profile of homozygous JAK2 617V>F mutation in patients with polycythemia vera or essential thrombocythemia. Blood, 110, 840 846.
29. Xu, M., Bruno, E., Chao, J., Ni, H., Lindgren, V., Nunez, R., Mahmud, N., Finazzi, G., Fruchtman, S.M., Popat, U., Liu, E., Prchal, J.T., Rondelli, D., Barosi, G. Hoffman, R. (2005) The constitutive mobilization of bone marrow-repopulating cells into the peripheral blood in idiopathic myelofibrosis. Blood, 105, 1699 1705.